Venous thrombosis associated with pernicious anaemia. A report of two cases and review

References

• Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. Serum total homocystein concentrations in the third National Health and Nutrition Examination Survey (1991-1994). Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Int Med 1999;131:331–339.
   PubMed Web of Science ®Google Scholar
• Nishinaga M, Ozawa T, Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Chin Invest 1993;92:1381–1386.
   PubMed Web of Science ®Google Scholar
• Harpel PC, Chang VT, Borth W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci 1992;89:10193–10197.
   PubMed Web of Science ®Google Scholar
• Khajuria A, Houston DS. Induction of monocyte tissue factor expression by homocysteine: A possible mechanism for thrombosis. Blood 2000;96:966–972.
   PubMed Web of Science ®Google Scholar
• Undas A, Williams EB, Butenas S, Orfeo T, Mann KG. Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem 2001;276:4389–4397.
   PubMed Web of Science ®Google Scholar
• Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1–31.
   PubMed Web of Science ®Google Scholar
• den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 1995;345: 882–885.
   PubMed Web of Science ®Google Scholar
• den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsner PH, et al. Hyperhomocysteinemia as a risk factor for deep-venous thrombosis. N Engl J Med 1996;334:759–762.
   PubMed Web of Science ®Google Scholar
• Simioni P, Prandoni P, Burlina A, Tormene D, Sardella C, Ferrari V, et al. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. Thromb Haemost 1996;76:883–886.
   PubMed Web of Science ®Google Scholar
• Langmann LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Hyperhomocysteinemia and the increased risk of venous thromboembolism: More evidence from a case-control study. Arch Int Med 2000;160:461–464.
   Google Scholar
• Quéré I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daures JP, et al. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: A matched case-control study. Lancet 2002;359:747–752.
   PubMed Web of Science ®Google Scholar
• den Heijer M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ. Hyperhomocysteinemia and venous thrombosis: A meta-analysis. Thromb Haemost 1998;80:874–877.
   PubMed Web of Science ®Google Scholar
• Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Int Med 1998;158:2101–2106.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997;95:1777–1782.
   PubMed Web of Science ®Google Scholar
• Tsai AW, Cushman M, Tsai MY, Heckbert SR, Rosamond WD, Aleksic N, et al. Serum homocystein, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Hematol 2003;72:192–200.
   PubMed Web of Science ®Google Scholar
• Eichinger S, Stampflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 1998;80:566–569.
   PubMed Web of Science ®Google Scholar
• Compher CW, Kinosian BP, Evans-Stoner N, Huzinec J, Buzby GP. Hyperhomocysteinemia is associated with venous thrombosis in patients with short bowel syndrome. J Parenter Enteral Nutr 2001;25:1–7.
   PubMed Web of Science ®Google Scholar
• Ray JG, Shmorgun D, Chan WS. Common 677T polymorph-ism of the methylenetetrahydrofolate reductase gene and the risk of thromboembolism: Meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002;32: 51–58.
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. Homocysteine and cardio-vascular disease: evidence on causality from a meta-analysis. Br Med J 2002;325:1202–1206.
   PubMed Web of Science ®Google Scholar
• Heckerling PS, Froelich CJ, Schade SG. Retinal vein thrombosis in a patient with pernicious anemia and anti-cardiolopin antibodies. J Rheumatol 1989;16:1144–1146.
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Baker RI. Venous thrombosis and hyper-homocysteinaemia. Med J Aust 1998;169:3135.
   Web of Science ®Google Scholar
• Cacoub P, Sbai A, Ohayon V, Ghafir D, Godeau P, Piette JC. Thrombose cave supérieure, anémie hémolytique et hyper-homocystéinémie. Presse Med 1998;27:64–65.
   PubMedGoogle Scholar
• Agarwal MB, Manocha S. Acquired hyperhomocysteinemia, megaloblastosis with subacute combined degeneration and deep venous thrombosis,. J Assoc Physicians India 2000;48:545–546.
   PubMedGoogle Scholar
• Thannberger P, Wilhelm JM, Ruxer S, Derragui A, Saraceni O, Kieffer P. Manifestations thrombotiques révélatrices d'une pathologie digestive. Rev Med Int 2000;21:371–372.
   PubMed Web of Science ®Google Scholar
• Marie I, Levesque H, Lecam-Duchez V, Borg JY, Ducrotté P, Philippe C. Mesenteric venous thrombosis revealing both factor II G20210A mutation and hyperhomocysteinemia related to pernicious anemia. Gastroenterology 2000;118: 237–238.
   PubMed Web of Science ®Google Scholar
• Karchafi A, Oualim Z, Amezyane T, Mahassin F, Ghafir D, Ohayon V, Archane MI. Maladie de Biermer et thrombose veineuse. A propos de deux observations. Rev Med Int 2002;23:563–566.
   PubMed Web of Science ®Google Scholar
• Soman R, Kanekar A. Jugular venous thrombosis in HIV-seropositive man. J Assoc Physicians India 2002;50:59.
   Google Scholar
• Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyerhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997;95:1777–1782.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Tsay MY, Bucciarelli P, Taoili E, Zighetti ML, Bignell M, et al. A common mutation in the methylenetetra-hydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol 1997;17: 1662-1666.
   PubMed Web of Science ®Google Scholar
• Klufitmans LA, Den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998;79:254–258.
   PubMed Web of Science ®Google Scholar
• Keijzer MB, den Heijer M, Blom HJ, Bos GM, Wilems HP, Gerrits WB, et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombo-sis. Thromb Haemost 2002;88:723–728.
   PubMed Web of Science ®Google Scholar
• Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191–1198.
   PubMed Web of Science ®Google Scholar